Literature DB >> 2186605

Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.

M A Hamilton1, L W Stevenson, J S Child, J D Moriguchi, M Woo.   

Abstract

Although acute afterload reduction is known to improve cardiac output in patients with congestive heart failure (CHF), the effect of therapy on the atrial overload directly causing congestive symptoms has not been systematically studied. Atrial volumes and mitral and tricuspid regurgitation, in addition to left ventricular ejection fraction and indexes of left ventricular contractility (mean acceleration, ejection time and peak systolic pressure/end-systolic volume index), were measured using 2-dimensional and Doppler echocardiography and color flow imaging in 30 patients with advanced CHF, before and after acute vasodilator and diuretic therapy tailored to hemodynamic goals. Therapy increased stroke volume by 64% (36 +/- 10 to 55 +/- 14 cc), decreased right atrial pressure by 45% (15 +/- 5 to 8 +/- 4 mm Hg), systemic vascular resistance by 36% (1,700 +/- 400 to 1,030 +/- 300 dynes s cm-5) and pulmonary capillary wedge pressure by 37% (31 +/- 6 to 19 +/- 6 mm Hg) (all p less than 0.001). Echocardiography showed simultaneous reductions in left and right atrial volumes: 24 +/- 19 and 18 +/- 12%, respectively (p less than 0.001). Mitral and tricuspid regurgitation measured by color flow fraction both decreased by a mean of 44% (p less than 0.001). While ejection fraction increased from 15 +/- 5 to 19 +/- 7% (p less than 0.001), there were no changes in relatively load-independent indexes of contractility. Therefore, acute therapy with vasodilators and diuretics in advanced CHF causes reductions in atrial volumes and atrioventricular valve regurgitation that are evident from serial noninvasive studies and may play a major role in the improvement of congestive symptoms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186605     DOI: 10.1016/0002-9149(90)90975-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Mitral regurgitation severity dynamic during acute decompensated heart failure treatment.

Authors:  Kamil Bugała; Paweł Rubiś; Mateusz K Hołda; Małgorzata Konieczyńska; Piotr Bijak; Wojciech Płazak
Journal:  Int J Cardiovasc Imaging       Date:  2021-12-22       Impact factor: 2.357

2.  Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial.

Authors:  B Seneviratne; G A Moore; P D West
Journal:  Br Heart J       Date:  1994-07

Review 3.  Nitroprusside in decompensated heart failure: what should a clinician really know?

Authors:  Cristina Opasich; Giovanni Cioffi; Alessandra Gualco
Journal:  Curr Heart Fail Rep       Date:  2009-09

4.  Rapid evaluation by lung-cardiac-inferior vena cava (LCI) integrated ultrasound for differentiating heart failure from pulmonary disease as the cause of acute dyspnea in the emergency setting.

Authors:  Katsuya Kajimoto; Keiko Madeen; Tomoko Nakayama; Hiroki Tsudo; Tadahide Kuroda; Takashi Abe
Journal:  Cardiovasc Ultrasound       Date:  2012-12-04       Impact factor: 2.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.